HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Sié Selected Research

P Sié Research Topics

Disease

3Acute Coronary Syndrome
07/2014 - 06/2011
2Thrombophilia
01/2020 - 10/2011
2Afibrinogenemia (Fibrinogen Deficiency)
02/2018 - 11/2016
2Atrial Fibrillation
10/2013 - 09/2011
1Urticaria (Hives)
11/2016
1Drug-Related Side Effects and Adverse Reactions
11/2016
1Chills
11/2016
1Cough
11/2016
1Exanthema (Rash)
11/2016
1Headache (Headaches)
11/2016
1Vomiting
11/2016
1Tangier Disease
03/2016
1Hemorrhage
10/2013
1Venous Thrombosis (Deep-Vein Thrombosis)
12/2012
1Pulmonary Embolism
12/2012
1Thrombocytopenia (Thrombopenia)
10/2011
1Stroke (Strokes)
09/2011
1Inflammation (Inflammations)
06/2011
1Atherosclerosis
06/2007
1Thrombosis (Thrombus)
06/2001
1Hemophilia A (Haemophilia)
01/2001
1Vascular System Injuries
07/2000

Drug/Important Bio-Agent (IBA)

3Thromboplastin (Tissue Factor)IBA
10/2011 - 07/2000
2AnticoagulantsIBA
01/2020 - 10/2013
2Fibrinogen (Factor I)FDA Link
02/2018 - 11/2016
2Prasugrel HydrochlorideFDA Link
07/2014 - 09/2012
2Clopidogrel (Plavix)FDA Link
07/2014 - 09/2012
2RivaroxabanIBA
10/2013 - 12/2012
1Vitamin KFDA Link
01/2020
1HDL LipoproteinsIBA
03/2016
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
03/2016
1CholesterolIBA
03/2016
1Apolipoprotein A-I (Apolipoprotein A1)IBA
03/2016
1TicagrelorIBA
07/2014
1Factor Xa InhibitorsIBA
10/2013
1N(4)-oleylcytosine arabinosideIBA
10/2013
1DabigatranFDA Link
10/2013
1Pharmaceutical PreparationsIBA
10/2013
1ThrombinFDA Link
10/2013
1Factor IIaIBA
10/2013
1AntibodiesIBA
10/2011
1Immunoglobulin G (IgG)IBA
10/2011
1Heparin (Liquaemin)FDA LinkGeneric
10/2011
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
09/2011
1SmokeIBA
06/2011
1Tobacco Smoke Pollution (Passive Smoking)IBA
06/2011
1Estrogens (Estrogen)FDA Link
06/2007
1CollagenIBA
06/2001
1Integrin beta3 (GPIIIa)IBA
06/2001
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2000

Therapy/Procedure

3Therapeutics
10/2011 - 01/2001
1Secondary Prevention
12/2012